Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05421728 · ClinicalTrials.gov registry record · NA

Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease

A NA study of Advance Care Planning and Primary Health Care, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
516
Enrollment target
8
Study locations

NCT05421728: Active NA study of Advance Care Planning and Primary Health Care, sponsored by University of Colorado, Denver.

NCT05421728 is a NA study of Advance Care Planning and Primary Health Care that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 516 participants, above the 453-participant average among 9 other Advance Care Planning trials with a reported enrollment target (14% higher). The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05421728, a NA study of Advance Care Planning and Primary Health Care, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
516 participants
Enrollment target
8
Study locations

Study Summary

The main goal of the ENACT (ENgaging in Advance Care planning Talks) Group Visit intervention is to integrate a patient-centered advance care planning process into primary care, ultimately helping patients to receive medical care that is aligned with their values. The ENACT Group Visit intervention involves two group discussions about advance care planning with 8-10 patients who meet for 2-hour sessions, one month apart, facilitated by a geriatrician and a social worker. This study will compare the ENACT Group Visit intervention to mailed advance care planning materials.

Primary Outcome

Number of Participants with New Advanced Care Planning (ACP) documentation in the electronic health record inclusive of advance directives (i.e., easy-to-read advance directive, medical durable power of attorney forms, living wills), and medical orders (POLST forms or CPR directives. If an advanced care planning document is completed and in patient's electronic health record, the participant will be counted as having a New ACP.

Interventions

  • BEHAVIORAL ENACT group visit
  • BEHAVIORAL Mailed Resources

Study Locations (8)

Colorado

  • UCHealth - Aurora
  • UC Health Boulder Family Medicine - Boulder
  • Denver Health Westside Clinic - Denver
  • UC Health Lowry Internal Medicine - Denver
  • UC Health AF Williams Family Medicine - Denver
  • UC Health Lone Tree Seniors - Lone Tree
  • UC Health Lone Tree Primary Care - Lonetree
  • UC Health Westminster Primary Care - Westminster

Trial Details

FieldValue
Enrollment Target 516 participants
Start Date 2022-07-26
Est. Completion 2027-05-01
Phase NA
University of Colorado, Denver

1,283 total trials

What the registry record for NCT05421728 still lists

NCT05421728 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, above the 453-participant average among 9 other Advance Care Planning trials with a reported enrollment target (14% higher).

The record links to 2 conditions, with Advance Care Planning appearing as the primary indexed condition, and to 2 interventions - of which ENACT group visit is the first listed.

NCT05421728 lists 8 locations in 1 state (Colorado).

Frequently Asked Questions

What is clinical trial NCT05421728 about?

NCT05421728 is a clinical study titled "Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease". The main goal of the ENACT (ENgaging in Advance Care planning Talks) Group Visit intervention is to integrate a patient-centered advance care planning process into primary care, ultimately helping patients to receive medical care that is aligned with their values. The ENACT Group Visit intervention ...

What is the current status of trial NCT05421728?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 516 participants. The study started on 2022-07-26. Estimated completion is 2027-05-01.

What conditions does trial NCT05421728 study?

This clinical trial studies the following conditions: Advance Care Planning, Primary Health Care.

What interventions are being tested in trial NCT05421728?

The interventions under investigation include: ENACT group visit (BEHAVIORAL), Mailed Resources (BEHAVIORAL).

Who is sponsoring clinical trial NCT05421728?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05421728 being conducted?

This trial has 8 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advance Care Planning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05421728's enrollment target sits among peer trials

516 4th of 9 higher than 6 of 9 other Advance Care Planning trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advance Care Planning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05933083 · 516 participants · NA

    MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

  • NCT05676450 · 517 participants · NA

    Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

  • NCT05577819 · 515 participants · NA

    Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

  • NCT06804837 · 515 participants · NA

    Implement and Test Visual Consent Template and Process

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05421728, the US trial registry maintained by the National Library of Medicine. NCT05421728 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.